Lactobacillus paracasei Lpc-37
Lacticaseibacillus paracasei Lpc-37 is among the better-studied commercial probiotic strains, with multiple randomized, double-blind, placebo-controlled trials in its literature record. Human RCTs, including the Sisu and ChillEx studies, have examined psychological stress markers and anxiety in healthy adults. Additional human research has examined immune function in elderly individuals, gut microbiota composition in young children, and short-chain fatty acid profiles. Animal and in vitro work has examined opioid and cannabinoid receptor expression in connection with visceral pain perception. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 51 body-system-tagged papers that concern each system. Research coverage, not measured effect.
+5 more systems
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 29 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+13 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
73 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 35634695 →Adjuvant use of multispecies probiotic in the treatment of peri‐implant mucositis: A randomized controlled trial· Journal Of Clinical Periodontology · 2022
-
[2]
PMID 32283645 →Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment· Biomedicines · 2020
-
[3]
PMID 33385020 →Lacticaseibacillus paracasei Lpc-37® improves psychological and physiological markers of stress and anxiety in healthy adults: a randomized, double-blind, placebo-controlled and parallel clinical trial (the Sisu study)· Neurobiology of Stress · 2020
-
[4]
Source →Health Benefits of a Combination Probiotics; FlorMidabil™· International Journal of Probiotics and Prebiotics · 2019
-
[5]
Source →Evaluation of the effect of Danisco products on Bifidobacterium Lactis Bi-07 and Lactobacillus Paracasei Lpc-37 on physical intestinal canal microbial eco-system· Chinese Journal of Disease Control and Prevention · 2011
-
[6]
Source →Clinical study on the health benefits of Danisco Bi-07 and Lpc-37 probiotic powder formulations on the gastrointestinal system丹尼斯克Bi-07及Lpc-37益生菌粉剂对胃肠道系统健康功效改善的临床研究· 中华疾病控制杂志 · 2011